Evidence map›Paper›PMID 35235537›Full record

ArticleEuropean journal of endocrinology2022

Homozygosity for a novel INHA mutation in two male siblings with hypospadias, primary hypogonadism, and high-normal testicular volume.

Esra Arslan Ates, Mehmet Eltan, Bahadir Sahin, Busra Gurpinar Tosun, Tuba Seven Menevse, Bilgen Bilge Geckinli, Andy Greenfield, Serap Turan, Abdullah Bereket, Tulay Guran

Open access · hybridAbstract read
In one paragraph

Article in European journal of endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. International journal of molecular sciences · 2024
    Article
  2. Review
  3. The first report on homozygous INHA inactivation in humans.European journal of endocrinology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Esra Arslan AtesMarmara University Pendik Training and Research Hospital, Genetic Diseases Diagnostic Center, Istanbul, Turkey.
Mehmet EltanDepartment of Pediatric Endocrinology and Diabetes, Marmara University, School of Medicine, Istanbul, Turkey.
Bahadir SahinDepartment of Urology, Marmara University, School of Medicine, Istanbul, Turkey.
Busra Gurpinar TosunDepartment of Pediatric Endocrinology and Diabetes, Marmara University, School of Medicine, Istanbul, Turkey.
Tuba Seven MenevseDepartment of Pediatric Endocrinology and Diabetes, Marmara University, School of Medicine, Istanbul, Turkey.
Bilgen Bilge GeckinliMarmara University Pendik Training and Research Hospital, Genetic Diseases Diagnostic Center, Istanbul, Turkey.
Andy GreenfieldMammalian Genetics Unit, MRC Harwell Institute, Oxfordshire, UK.
Serap TuranDepartment of Pediatric Endocrinology and Diabetes, Marmara University, School of Medicine, Istanbul, Turkey.
Abdullah BereketDepartment of Pediatric Endocrinology and Diabetes, Marmara University, School of Medicine, Istanbul, Turkey.
Tulay GuranDepartment of Pediatric Endocrinology and Diabetes, Marmara University, School of Medicine, Istanbul, Turkey.ORCID 0000-0003-2658-6866
Marmara University · TRMary Lyon Centre at MRC Harwell · GB

Funding

Medical Research Council MC_U142684167
6 · The paper itself

Abstract

Background: The human INHA gene encodes the inhibin subunit alpha protein, which is common to both inhibin A and B. The functional importance of inhibins in male sex development, sexual function, and reproduction remain largely unknown. Objective: We report for the first time two male siblings with homozygous INHAmutations. Methods: The medical files were examined for clinical, biochemical, and imaging data. Genetic analysis was performed using next-generation and Sanger sequencing methods. Results: Two brothers complained of gynecomastia, testicular pain, and had a history of hypospadias. Biochemistry revealed low serum testosterone, high gonadotropin and anti-Mullerian hormone, and very low/undetectable inhibin concentrations, where available. Both patients had azoospermia in the spermiogram. We have identified a homozygous 2 bp deletion (c.208_209delAG, R70Gfs*3) variant, which leads to a truncated INHA protein in both patients, and confirmed heterozygosity in the parents. The external genital development, pubertal onset and progression, reproductive functions, serum gonadotropins, and sex hormones of mother and father, who were heterozygous carriers of the identified mutation, were normal. Conclusion: Homozygosity for INHA mutations causes decreased prenatal and postnatal testosterone production and infertility in males, while the heterozygous female and male carriers of INHA mutations do not have any abnormality in sex development and reproduction.

Indexed as

HypogonadismHypospadiasFemaleHumansInhibinsMaleMutationSiblingsTestisinhibin-alpha subunitInhibins

Identifiers

PMID35235537
PMCPMC9010807
OpenAlexW4214933725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.